§ Mr. McNamaraTo ask the Secretary of State for Health when he will complete his discussions with the pharmaceutical industries on the provision of beta interferon for relapsing-remitting MS sufferers. [14799]
§ Ms BlearsWe have no precise timetable, but are aiming to conclude the discussions as soon as possible in the light of the National Institute for Clinical Excellence's final guidance.